Isabelle Ling Meng

733 total citations
9 papers, 507 citations indexed

About

Isabelle Ling Meng is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Hematology. According to data from OpenAlex, Isabelle Ling Meng has authored 9 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 5 papers in Internal Medicine and 1 paper in Hematology. Recurrent topics in Isabelle Ling Meng's work include Atrial Fibrillation Management and Outcomes (9 papers), Cardiac Arrhythmias and Treatments (8 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). Isabelle Ling Meng is often cited by papers focused on Atrial Fibrillation Management and Outcomes (9 papers), Cardiac Arrhythmias and Treatments (8 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). Isabelle Ling Meng collaborates with scholars based in Germany, United Kingdom and Italy. Isabelle Ling Meng's co-authors include Riccardo Cappato, Martin van Eickels, Michael D. Ezekowitz, Stefan H. Hohnloser, A. John Camm, Paulus Kirchhof, Gregory Y.H. Lip, Francisco Marı́n, Christoph Hammerstingl and Mario Talajic and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Heart Journal and American Heart Journal.

In The Last Decade

Isabelle Ling Meng

9 papers receiving 493 citations

Peers

Countries citing papers authored by Isabelle Ling Meng

Since Specialization

Citations

This map shows the geographic impact of Isabelle Ling Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Ling Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Ling Meng more than expected).

Fields of papers citing papers by Isabelle Ling Meng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Ling Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Ling Meng. The network helps show where Isabelle Ling Meng may publish in the future.

Co-authorship network of co-authors of Isabelle Ling Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Ling Meng. A scholar is included among the top collaborators of Isabelle Ling Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Ling Meng. Isabelle Ling Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Predictors of sinus rhythm 6 weeks after cardioversion of atrial fibrillation: a pre-planned post hoc analysis of the X-VeRT trial 2021 ·EP Europace ·Riccardo Cappato, Michael D. Ezekowitz, Stefan H. Hohnloser, Isabelle Ling Meng, (unknown), (unknown)	1
2	Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial 2020 ·SHILAP Revista de lepidopterología ·Paulus Kirchhof, Michael D. Ezekowitz, Yanish Purmah, Sonja Schiffer, Isabelle Ling Meng, A. John Camm, Stefan H. Hohnloser, (unknown), (unknown), Riccardo Cappato	32
3	Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA) 2018 ·Annals of Medicine ·Kazuo Miyazawa, Daniele Pastori, Christoph Hammerstingl, Riccardo Cappato, Isabelle Ling Meng, Frank Kramer, Ariel Cohen, (unknown), Martin van Eickels, Gregory Y.H. Lip, Francisco Marı́n	12
4	Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF) 2016 ·American Heart Journal ·Gregory Y.H. Lip, Christoph Hammerstingl, Francisco Marı́n, Riccardo Cappato, Isabelle Ling Meng, Bodo Kirsch, Martin van Eickels, Ariel Cohen	120
5	Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF) 2015 ·American Heart Journal ·Gregory Y.H. Lip, Christoph Hammerstingl, Francisco Marı́n, Riccardo Cappato, Isabelle Ling Meng, Bodo Kirsch, (unknown), Martin van Eickels, Ariel Cohen	18
6	Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: apost hocanalysis of the X-VeRT trial 2015 ·EP Europace ·Stefan H. Hohnloser, Riccardo Cappato, Michael D. Ezekowitz, Thomas Evers, Kurtuluş Şahin, Paulus Kirchhof, Isabelle Ling Meng, Martin van Eickels, A. John Camm	26
7	Rationale and design of the eXplore the efficacy and safety of once-daily oral riVaroxaban for the prEvention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion trial: A comparison of oral rivaroxaban once daily with dose-adjusted vitamin K antagonists in patients with nonvalvular atrial fibrillation undergoing elective cardioversion 2014 ·American Heart Journal ·Michael D. Ezekowitz, Riccardo Cappato, Allan L. Klein, A. John Camm, (unknown), Jean-Yves Le Heuzey, Mario Talajic, Maurício Scanavacca, Panos Vardas, Paulus Kirchhof, Stefan H. Hohnloser, Melanie Hemmrich, Vivian Lanius, Isabelle Ling Meng, Peter Wildgoose, Martin van Eickels	19
8	Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation 2014 ·European Heart Journal ·Riccardo Cappato, Michael D. Ezekowitz, Allan L. Klein, A. John Camm, Changsheng Ma, Jean‐Yves Le Heuzey, Mario Talajic, Maurício Scanavacca, Panos Vardas, Paulus Kirchhof, Melanie Hemmrich, Vivian Lanius, Isabelle Ling Meng, Peter Wildgoose, Martin van Eickels, Stefan H. Hohnloser	255
9	Rivaroxaban for the treatment of symptomatic deep-vein thrombosis and pulmonary embolism in Chinese patients: a subgroup analysis of the EINSTEIN DVT and PE studies 2013 ·Thrombosis Journal ·Yuqi Wang, Chen Wang, Zhong Chen, Jiwei Zhang, Zhihong Liu, (unknown), Kejing Ying, Changwei Liu, (unknown), Zhi‐Cheng Jing, Isabelle Ling Meng, Martin H. Prins, Ákos F. Pap, Katharina Müller, Anthonie WA Lensing, (unknown)	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact